Here’s how the CSL (ASX:CSL) share price performed in April

The CSL Limited (ASX: CSL) share price had a better month during April.

Although it underperformed the S&P/ASX 200 Index (ASX: XJO), it recorded a 2.5% gain over the 30 days.

This means the CSL share price is now down just 5% year to date and up 12% from its March low.

Why did the CSL share price recover in April?

The CSL share price has come under significant pressure over the last 12 months due to concerns over plasma collections.

Plasma is a key ingredient in many of the biotherapeutics company’s therapies such as immunoglobulins and albumin.

It needs to be collected from willing donors on a regular basis via CSL’s widespread collection centres. However, the COVID-19 pandemic has made collections very difficult for a…